Have an account?
Log in to check out faster.
Loading...
May, 2024
June, 2024
Learn why you should start your probiotics journey with Bio-K+
Our scientifically proven formulas are designed to support your unique health journey
For healthy children, probiotics from Lactobacillus and Bifidobacterium species are generally considered safe. Safety depends on age, health status, and strain. Always consult your child's healthcare provider before starting any supplement.
Probiotics from Lactobacillus and Bifidobacterium species are generally safe for healthy children, with serious adverse events rare and mostly limited to immunocompromised or critically ill cases. Mild, temporary side effects like gas or bloating may occur as the gut adjusts. Children who are immunocompromised, premature, or have central lines should only use probiotics under medical supervision. The Canadian Pediatric Society notes possible benefits for atopic dermatitis but does not currently recommend probiotics for other atopic disease prevention.
Pediatric guidance recommends consulting a pediatrician before giving probiotics to infants, since Safety data are limited for kids under one. Breastfeeding provides beneficial bacteria and prebiotics that support the development of the infant's gut microbiome. Healthy children over one can generally take probiotics with a good safety record under a pediatrician's guidance. For school-age children, strain and format choice depend on the child's circumstances. Always discuss with a healthcare provider.
The most commonly reported side effects are mild and temporary: gas, bloating, or loose stools during the first few days, typically resolving as the digestive system adjusts. Serious adverse events are very rare in healthy children; complications are limited to those with compromised immune systems, serious illness, or central lines (PMC8308463). If a child experiences persistent discomfort or unusual symptoms, discontinue use and consult a healthcare provider. Always check product allergens and confirm a valid Health Canada NPN.
Children who are immunocompromised, receiving cancer treatment, or critically ill shouldn’t be given probiotics without guidance from their healthcare team. Premature infants or newborns in hospital settings require dedicated medical oversight before any probiotic is used. Children with a central intravenous line or port should avoid probiotics unless specifically cleared by their physician, as rare but documented complications have been reported in this group. When using probiotics alongside antibiotics, consult a pharmacist or pediatrician for timing guidance.
Probiotic research in children shows that strain-specific benefits don’t transfer between strains. Lacticaseibacillus rhamnosus GG is the most widely studied strain in children and is recommended by the Canadian Family Physician (PMC7012114) for pediatric antibiotic-associated diarrhea alongside Saccharomyces boulardii. Lacticaseibacillus reuteri DSM 17938 is studied for colic and regurgitation (CDHF, 2026). Saccharomyces boulardii CNCM I-745 is studied for antibiotic-associated diarrhea treatment. These are third-party research findings; no Bio-K+ product claim is attached.
A valid Health Canada NPN confirming safety and quality review. Require full strain names with complete genus, species, and alphanumeric codes; a generic "probiotic blend" without specific designations cannot be matched to pediatric research. Confirm CFU is guaranteed until the best-before or expiry date, not at manufacture. Check format and allergens: powder, liquid, chewable, and capsule formats differ; always review for dairy, soy, and gluten before giving to your child.
In Canada, probiotic supplements for children are regulated as Natural Health Products and must carry a valid NPN confirming Health Canada review for safety and quality. Some products are classified as foods and regulated under food labeling rules. No Canadian probiotic holds a Health Canada-approved claim to treat or prevent any condition. Approved claims are limited to intestinal flora and gastrointestinal support. Bio-K+ products carry valid NPNs and make only authorized claim language.
For healthy children, probiotics from Lactobacillus and Bifidobacterium species are generally considered safe, and serious adverse events are very rare, with most reported in immunocompromised or critically ill children (PMC8308463). Mild, temporary digestive effects such as gas or bloating may occur when starting a probiotic. Always consult your child's healthcare provider before starting any probiotic supplement.
Most published pediatric safety evidence covers children aged 1 year and older. Current pediatric guidance recommends consulting a healthcare provider before administering probiotics to infants under 12 months, given limited safety data in this age group. For children aged 1 and older, probiotics with a strong pediatric safety record are generally considered appropriate under the guidance of a healthcare provider.
The most common side effects are mild and temporary: gas, bloating, or loose stools during the first few days of use, which typically resolve on their own. Serious side effects are very rare in healthy children. If a child develops persistent or unusual symptoms after starting a probiotic, stop use and consult a healthcare provider promptly.
Probiotics should be avoided or used only under direct medical supervision in children who are immunocompromised, critically ill, receiving cancer treatment, or who are premature newborns. Children with central venous catheters or ports require physician guidance before using probiotics. When in doubt, always consult your child's pediatrician or healthcare provider before starting any supplement.
Look for a valid Health Canada NPN, the complete strain name with alphanumeric designation, and CFU guaranteed until the best before date or expiry date, not at the time of manufacture. Check for allergens and added ingredients that may not be suitable for your child. Consult the Canadian Probiotic Chart (probioticchart.ca) or your child's healthcare provider for evidence-based strain guidance.
Follow @biokplus and tag us to be mentioned
